Target: 1,000 mcg total blend daily (~500 mcg each) by Weeks 38
this is the form that needs medical supervision and sensible dosing
Common neurologic manifestations include paresthesias, weakness, gait abnormalities, and cognitive or behavioral changes
Molecular pharmacology of topiramate: Managing seizures and preventing migraine
Turella P, Cerella C, Filomeni G, Bullo A, De Maria F, Ghibelli L, Ciriolo MR, Cianfriglia M, Mattei M, Federici G, Ricci G, Caccuri AM (2005) Proapoptotic activity of new glutathione S-transferase inhibitors